NOTE: Although this activity is no longer certified for credit, we believe that it contains important information and hope you’ll review, print or email it to a colleague.
Diagnosing Type 2 Diabetes Mellitus Using the A1C Assay
1.00 AMA PRA Category 1 Credits, 1.00 AANP, 1.00 ANCC
State at least 3 recommendations advanced by the International Expert Committee with respect to adopting the A1C assay as a valid diagnostic tool for type 2 diabetes mellitus, and list at least 3 the implications this is likely to have on clinical practice in the US and worldwide.
This educational program is conceived and credited in accordance with ACCME's Essential Areas and Policies, including the 2004 Updated Standards for Commercial Support. Pri-Med faculty hail from a variety of institutions and participate in content development, along with Pri-Med Institute's Advisory Boards and its expert review partners, the University of Wisconsin School of Medicine and Public Health and Tufts Health Care Institute. All final decisions about program content are the responsibility of Pri-Med Institute.
||AMA PRA Category 1 Credits
||Pri-Med Institute is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
||Pri-Med Institute designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
||Pri-Med Institute is approved as a provider of nurse practitioner continuing education programs by the American Academy of Nurse Practitioners. AANP Provider number 040308.
||This program has been approved for 1 contact hours of continuing education, which includes .5 hours of pharmacology.
||Pri-Med Institute is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
||This activity for 1 contact hours is provided by Pri-Med Institute.
Faculty and Editorial Board
Vivian Fonseca, MD, Professor of Medicine, Tullis-Tulane Chair in Diabetes, Chief, Section of Endocrinology, Tulane University Health Sciences Center
M. Sue Kirkman, MD, Vice President, Clinical Affairs of the American Diabetes Association (ADA)
Kate Rouhana, BA, MA, Pri-Med Institute
Financial Disclosure Statement(s)
Dr Fonseca has no financial relationships to disclose.
The content collaborators at the American Diabetes Association have no financial relationships to disclose.
Dr Kirkman has no financial relationships to disclose.
Ms Rouhana has no financial relationships to disclose.
American Diabetes Association
Amylin Pharmaceuticals, Inc. and Eli Lilly and Company, Novo Nordisk Inc., Merck & Co., Inc.
Instructions for Obtaining Credit:
Complete this activity. Answer the questions in the attached posttest and evaluation. Click on "claim credit" and follow the instructions to print out the credit certificate.
Computer System Requirements:
The opinions, ideas, and recommendations expressed in this educational activity are those of the faculty only and are not necessarily endorsed, nor do they necessarily reflect, those of their affiliated institutions, Pri-Med Institute, Pri-Med Institute Advisory Boards and Consultants, or M|C Communications, LLC.
Clinical judgment must guide each clinician in weighing the possible risks, benefits, or contraindications of any diagnostics, interventions or treatments discussed. Clinicians should review manufacturers’ product information and consider these with the recommendations of other authorities when applying the assessment and/or clinical management strategies discussed in this activity to the care of their patients.